A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects

NCT05815680 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight Subjects
Obese Subjects

Interventions

DRUG: metformin
DRUG: digoxin
DRUG: IBI362
DRUG: warfarin
DRUG: atorvastatin

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.